Jasper Therapeutics Inc (NASDAQ: JSPR) — Healthcare · Share Price, Chart & Market Data
About: Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases. The company's lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factor from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercialization of therapeutic agents for patients with various mast cell driven diseases, including chronic spontaneous urticaria, chronic inducible urticaria, and asthma, as well as conditioning agents for stem cell transplant in patients with sickle cell disease, Fanconi anemia, and severe combined immunodeficiency. Jasper Therapeutics, Inc. was founded in 2018 and is based in Redwood City, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.84 (-7.37%)
JSPRJasper Therapeutics Inc
Loading watchlist status…
Trade JSPR now
Jasper Therapeutics Inc share price
JSPR price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 7:28 am GMT+0
JSPR price performance
-20.906%
5D
-27.096%
1M
-54.435%
YTD
-82.855%
1Y
JSPR price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 7:28 am GMT+0
JSPR details
JSPR Market Signals